Literature DB >> 7688093

Use of mathematical models for understanding the dynamics of gene amplification.

L E Harnevo1, Z Agur.   

Abstract

Recently it has been suggested that high levels of cancer drug resistance and poor prognosis are strongly associated with gene or oncogene amplification (GA). It has been further suggested that the molecular mechanisms underlying GA may be different for different genes, and that different amplification mechanisms may function concurrently or sequentially in the same gene. The aim of this review is to demonstrate the use of mathematical models in studying these intricate dynamics. We have provided mathematical models for the generation of extrachromosomal elements, their autonomous replication and equal or unequal mitotic segregation, the integration of the extrachromosomal elements within the chromosomes, and chromosomal GA in one or many unlinked genes. Using this formal description one can examine the potential role of each GA mechanism in the generation of specific distributions of gene-copy number in a cell population, under various levels of selection stringency. Thus one can specify the conditions for the emergence of drug-resistant mutants prior to selection, as well as the relationships between the stringency of the selecting environment and the characteristics of the resultant cellular phenotype.

Entities:  

Mesh:

Year:  1993        PMID: 7688093     DOI: 10.1016/0165-1161(93)90004-j

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  5 in total

1.  An elementary approach to modeling drug resistance in cancer.

Authors:  Cristian Tomasetti; Doron Levy
Journal:  Math Biosci Eng       Date:  2010-10       Impact factor: 2.080

2.  On the probability of random genetic mutations for various types of tumor growth.

Authors:  Cristian Tomasetti
Journal:  Bull Math Biol       Date:  2012-02-07       Impact factor: 1.758

Review 3.  Mathematical modeling as a tool for planning anticancer therapy.

Authors:  Andrzej Swierniak; Marek Kimmel; Jaroslaw Smieja
Journal:  Eur J Pharmacol       Date:  2009-10-13       Impact factor: 4.432

4.  Efficacy of weekly docetaxel and bevacizumab in mesenchymal chondrosarcoma: a new theranostic method combining xenografted biopsies with a mathematical model.

Authors:  Boris Gorelik; Irit Ziv; Revital Shohat; Michael Wick; W David Hankins; David Sidransky; Zvia Agur
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

5.  Optimizing combination therapies with existing and future CML drugs.

Authors:  Allen A Katouli; Natalia L Komarova
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.